retatrutide usa ESC 2024: improves lipid and cardiovascular risk profile in Phase II trial Retatrutide, an experimental weight-loss drug,
Description
Minimising alcohol consumption, particularly around injection days or dose increases, is also advisable
Larry M
The retatrutide peptide represents a new frontier in metabolic science, not only for obesity but also for insulin resistance, fatty liver disease, cardiovascular risk, and type 2 diabetes complications
[DOI] [PMC free article] [PubMed] [Google Scholar] 12.Ramos-Lobo AM, Donato J
